| Identification | Back Directory | [Name]
Amg 517 | [CAS]
659730-32-2 | [Synonyms]
CS-691
Amg 517
AMG517; AMG-517
N-[4-[[6-[4-(Trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]acetamide
AcetaMide, N-[4-[[6-[4-(trifluoroMethyl)phenyl]-4-pyriMidinyl]oxy]-2-benzothiazolyl]-
N-(4-((6-(4-(Trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)benzo[d]thiazol-2-yl)acetamide
N-[4-[[6-[4-(Trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]acetamide AMG517 | [Molecular Formula]
C20H13F3N4O2S | [MDL Number]
MFCD14584859 | [MOL File]
659730-32-2.mol | [Molecular Weight]
430.4 |
| Chemical Properties | Back Directory | [Melting point ]
227℃ | [density ]
1.458 | [storage temp. ]
Store at -20°C | [solubility ]
≥21.5 mg/mL in DMSO; insoluble in H2O; ≥4.93 mg/mL in EtOH | [form ]
solid | [pka]
10.19±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
AMG-517 is a novel TRPV1 antagonist. | [Biological Activity]
AMG517 is an orally activehighly potent and selective vanilloid receptor-1 (TRPV1; VR1; capsaicin receptor) antagonist th at blocks TRPV1-mediated cellular Ca2+ influx (h/r/m IC50/stimulant = 0.76 nM/1.01 nM/1.9 nM/500 nM capsaicin; 0.62 nM/0.5 nM/0.63 nM/acid (pH 5) using respective CHO transfectants; IC50 >20 μM against TRPV2/3/4TRPA1and TRPM8-mediated responses; <45% binding at 10 μM to 87 receptorsenzymesand ion channels) and exhibits antihyperalgesic efficacy in vivo (capsaicin-induced flinch = ED50 = 0.33 mg/kg ratsp.o.; CFA-induced thermal hyperalgesiaMED = 0.83 mg/kg ratsp.o.). | [storage]
Store at +4°C |
|
|